S. Becker

Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies.

P. Wingo, N. Lee, H. Peterson, 1990 .

670PA randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)

M. Egger, A. Vogel, S. Al-Batran, 2017 .

Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies

P. Wingo, N. Lee, H. Peterson, 1990, American journal of obstetrics and gynecology.

Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center

J. Huebner, H. Serve, B. Senf, 2013, Journal of Cancer Research and Clinical Oncology.

Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial

A. Hinke, H. Schmoll, A. Tannapfel, 2016 .